NEW YORK (GenomeWeb News) - Shares in CombiMatrix were down 10 percent, or $.14, at $1.22 in mid-afternoon trading today after the company reported a decline in revenues for the second quarter.
As GenomeWeb News reported today, total revenues declined 3.5 percent to $1.79 million, though revenues from product sales more than doubled.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.